Geographical variation in mortality from systemic lupus erythematosus in the United States
暂无分享,去创建一个
S. Walsh | S. Walsh | S J Walsh | L. DeChello | L M DeChello | LM DeChello
[1] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[2] M. Liang,et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. , 2000, The Journal of rheumatology.
[3] J. Reveille,et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis , 2000 .
[4] A. Gedalia,et al. Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. , 1999, Journal of the National Medical Association.
[5] G. Sturfelt,et al. A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups. , 1999, Journal of autoimmunity.
[6] N. Goel,et al. Systemic lupus erythematosus in three ethnic groups: IV. Factors associated with self‐reported functional outcome in a large cohort study , 1999 .
[7] J. Reveille,et al. Systemic lupus erythematosus in three ethnic groups: V. Acculturation, health‐related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA Cohort , 1999 .
[8] L. Vilá,et al. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus , 1999, Lupus.
[9] J. Morrison,et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. , 1999, Human molecular genetics.
[10] J. Reveille,et al. Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort , 1999 .
[11] N. Goel,et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course , 1998 .
[12] J. Reveille,et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset , 1998 .
[13] F. Medina,et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration , 1998, Lupus.
[14] A. Gharavi,et al. Ethnic differences in the clinical expression of systemic lupus erythematosus: A comparative study between African-Americans and Latin Americans , 1997, Lupus.
[15] K. Kilburn. Geographic clusters of systemic lupus erythematosus: comment on the review by Wallace and Quismorio. , 1996, Arthritis and rheumatism.
[16] D. Alarcón-Segovia,et al. The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans , 1996, Lupus.
[17] D. Wallace,et al. The elusive search for geographic clusters of systemic lupus erythematosus. Critical review. , 1995, Arthritis and rheumatism.
[18] D. Gregorio,et al. Divergent racial trends in mortality from systemic lupus erythematosus. , 1995, The Journal of rheumatology.
[19] C. Kwoh,et al. Incidence of systemic lupus erythematosus. Race and gender differences. , 1995, Arthritis and rheumatism.
[20] S. Wing,et al. United States mortality from ill-defined causes, 1968-1988: potential effects on heart disease mortality trends. , 1995, International journal of epidemiology.
[21] M Kulldorff,et al. Spatial disease clusters: detection and inference. , 1995, Statistics in medicine.
[22] E. Karlson,et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. , 1995, Arthritis and rheumatism.
[23] F. Arnett,et al. Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus. , 1995, Tissue antigens.
[24] S. Studenski,et al. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. , 1995, Arthritis and rheumatism.
[25] M. Doherty,et al. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. , 1994, Annals of the rheumatic diseases.
[26] A. Friede,et al. CDC WONDER: a comprehensive on-line public health information system of the Centers for Disease Control and Prevention. , 1993, American journal of public health.
[27] K. Kilburn,et al. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. , 1992, Environmental research.
[28] J. Samet,et al. Symptoms, signs, and ill-defined conditions: a leading cause of death among minorities. , 1990, American journal of epidemiology.
[29] S. Studenski,et al. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. , 1990, Archives of internal medicine.
[30] S. Studenski,et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. , 1987, Arthritis and rheumatism.
[31] D. Clayton,et al. Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. , 1987, Biometrics.
[32] T. J. Breen,et al. Biostatistical Analysis (2nd ed.). , 1986 .
[33] J. Fries,et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. , 1982, Arthritis and rheumatism.
[34] W. Hauser,et al. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. , 1969, Mayo Clinic proceedings.
[35] R. Jacox,et al. The death certificate in rheumatoid arthritis. , 1967, Arthritis and rheumatism.
[36] A. Masi,et al. Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore. , 1967, Annals of internal medicine.
[37] K. Short,et al. Experimental poverty measures : 1990 to 1997 , 1999 .
[38] J Thumboo,et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. , 1999, Arthritis and rheumatism.
[39] J. Alcocer-Varela,et al. Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. , 1998, Scandinavian journal of rheumatology.
[40] M. Liang,et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[41] J. Reveille,et al. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. , 1990, Arthritis and rheumatism.
[42] J. Reveille,et al. Prognosis in systemic lupus erythematosus , 1990 .
[43] Norman E. Breslow,et al. The design and analysis of cohort studies , 1987 .
[44] M. Laakso,et al. Death certificate and mortality in rheumatoid arthritis. , 1986, Scandinavian journal of rheumatology.
[45] P. Allebeck,et al. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. , 1981, Scandinavian journal of rheumatology.
[46] Stanley L. Lee,et al. The epidemiology of systemic lupus erythematosus. , 1973, Seminars in arthritis and rheumatism.
[47] C Rouquette,et al. [Epidemiologic research]. , 1970, Bulletin de l'Institut national de la sante et de la recherche medicale.
[48] T. Leonhardt. FAMILY STUDIES IN SYSTEMIC LUPUS ERYTHEMATOSUS. , 1964, Acta medica Scandinavica.